Grace Yu

Grace Yu is one of the funding members of CBVM. She was actively involved in the investments of Peninsula Pharmaceuticals （acquired by JNJ）， Cerexa （Acquired by Forest Laborartory）， Pharmasset， Targacept， Renovis， Santarus and Cameron Health. She currently serves as a Board Observer in Epiphany BioSciences. Prior to join CBVM， she was an investment manager in the Life Science Investment Unit at China Development Industrial Bank. Dr. Yu received her Ph.D. and M.S. in molecular biology and genetics from University of Illinois at Urbana-Champaign. Now she is Senior Director of Operation and Investment （US Office） of CDIB BioScience Venture Management （USA） ， Inc.